Fig. 2 | Scientific Reports

Fig. 2

From: Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study

Fig. 2

Health-related quality of life (QoL) in patients with NPS assessed using the RAND 36-Item Short Form (SF-36) health survey at baseline (M0) and after 3 months (M3) of treatment with synthetic cannabidiol. (a) Radar plots of mean QoL scores for the 8 domains of physical and mental health in subjects with paired data (N = 27): physical functioning (PF), role limitations due to physical health problems (RF), bodily pain (BP), perception of general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). *p < 0.05, and **p < 0.001. (b) Individual changes between baseline and M3 in scores for the 8 domains presented as stacked histograms showing the number and percentage of patients by category for each ___domain: health-related QoL improved, unchanged or worsened at M3 (N = 27).

Back to article page